BEAM:BMV
Beam Therapeutics Inc
MX$453.00
arrow_downward
-0.58%(-2.65) 1D
Oct 8, 7:30:20 AM GMT-6 · MXN
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BEAM...
Mkt. cap
2.49B
Avg. vol.
13.00
Volume
0.00
52-wk high
MX$663.44
52-wk low
MX$384.79
No. of employees
540
Mkt. cap
2.49B
Avg. vol.
13.00
Volume
0.00
52-wk high
MX$663.44
52-wk low
MX$384.79
No. of employees
540
News stories
From web sources and news partners
Yahoo Finance
·
1 day ago
Cathie Wood Keeps Buying Beam Therapeutics on the Dip. Should You Follow Her Lead?
Investing.com Australia
·
2 days ago
Form 144 BEAM THERAPEUTICS INC. For: 17 October By Investing.com
Profile
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks. Wikipedia
About Beam Therapeutics Inc